The relative susceptibility of different developmental stages of Plasmodium berghei to cydosporine was investigated in vivo. Within 12 h of receiving a single 25-mg/kg (body weight) dose of cyclosporine, mice with patent P. berghei infections uniformly exhibited a rapid fall in asexual parasite stages. Initially, ring forms and mature schizonts disappeared. Subsequently, trophozoites disappeared between 21 and 24 h, whereas gametocytes persisted for 36 h. In contrast, when cyclosporine was administered to mice 1 day before inoculation (100 mg/kg) with P. berghei sporozoites and for 2 consecutive days after inoculation (25 mg/kg), infections developed normally. When mice with patent infections were placed on prolonged cyclosporine therapy (25 mg/kg per day), parasitemia initially disappeared but often recrudesced. Recrudescent parasites were frequently resistant to cyclosporine (Csr). The Csr phenotype remained stable after serial passage of parasites in mice and after transmission through Anopheles stephensi mosquitoes, in which the capacity to produce oocysts was reduced. When infections of untreated mice were initiated with equal numbers of Csr and cyclosporine-susceptible (Css) parasites and then carried through two serial cycles of mosquito-to-mouse transmission without cyclosporine treatment, the Csr phenotype was lost. The results indicate that cyclosporine selectively inhibits asexual blood stages of P. berghei and favors the emergence of Csr parasites with diminished infectivity for mosquitoes.
Recent studies (3, 5, 8) show that the cyclic undecapeptide cyclosporine has a potent antiplasmodial activity which is unrelated to the better known suppressive action of the drug on mammalian T-lymphocyte functions (1, 10) . In mice infected with blood stages of Plasmodium berghei (5), Plasmodium yoelii (5) , or Plasmodium chabaudi (8) and in owl monkeys infected with Plasmodiumfalciparum (3) , normally rising levels of parasitemia are aborted and become undetectable after appropriate parenteral treatment with cyclosporine. Furthermore, when mice are inoculated with infectious blood stages of P. berghei or P. yoelii, three to four daily subcutaneous 25-mg/kg (body weight) doses of cyclosporine (initiated at the time of the infective inoculation) prevent the development of malaria (5) . In both mice and monkeys, it appears that the earliest detectable fall in the level of parasitemia due to cyclosporine treatment coincides with a selective depletion of circulating ring forms (5) . Moreover, in both species parasitemias "cured" by treatment with cyclosporine often recrudesce several days later and tend to be resistant to further cyclosporine treatment (5) .
These observations formed the basis for the present study, in which the major aims were (i) to identify the cyclosporinesusceptible (Css) stage(s) in the P. berghei life cycle and (ii) to examine and compare the stability and biologic properties of the cyclosporine-resistant (Cs') phenotype with those of the Css phenotype.
MATERIALS AND METHODS
Plasmodia. P. berghei NK-65 (Css) was obtained from G. Spitalny, Trudeau Institute, Saranac Lake, N.Y. Ampoules of stock parasites (parasitized mouse erythrocytes [PRBC] in Alsever solution containing 10% glycerin) were stored at -70°C and were thawed and passaged once in mice before use in experiments. For selected experiments, the parasites were passed sequentially from mouse to mouse by Anopheles stephensi or syringe transfer of infected blood.
A Csr parasite population was obtained from mice infected with Css P. berghei and subsequently treated with cyclosporine (25 mg/kg per day) through day 24 of infection, as described previously by Nickell et al. (5) . The Csr parasites were passaged once through A. stephensi and twice through mice before being used to prepare a frozen stock.
Mosquitoes and mice. A mutant eye (rosy) strain of A. stephensi (4) (obtained from R. Sakai, University of Maryland International Center for Medical Research and Training, Lahore, Pakistan) was used in transmission experiments. Outbred 6-to 8-week-old female albino mice served as the experimental hosts.
Mosquito transmission. Infected mice with mature circulating gametocytes were restrained for 12 h in cages of adult A. stephensi in a 19°C incubator. Fully engorged females were separated and held at 19°C for 9 to 11 days for quantitation of oocysts or for 18 to 24 days when used as a source of sporozoites. Transmission of parasites to mice was accomplished either by allowing infected mosquitoes to feed (as described above) or by intravenous (i.v.) injection of 0.2 ml of a sporozoite suspension. The latter was prepared by triturating salivary glands in saline and subjecting the resulting suspension to low-speed centrifugation (50 x g) to remove debris.
Parasitemia. Parasitemia levels were determined from Giemsa-stained blood smears. Oocysts. Mosquito midguts were dissected in normal saline on microscope slides and flattened with a cover slip. Their contents of oocysts were counted by using a phasecontrast microscope.
Cyclosporine and chloroquine treatments. Cyclosporine (provided by J. Borel, Sandoz Ltd., Basel, Switzerland) was dissolved in Emulphor El 620 (donated by GAF Corp., New York, N.Y.) at a ratio of 100 mg/2 ml and further diluted with distilled water to achieve the desired drug concentration. Chloroquine hydrochloride (Winthrop Laboratories, New York, N.Y.) was dissolved in saline to a concentration of 300 mg/ml. Both drugs were administered subcutaneously in the flank.
RESULTS
Characteristics of Css and Csr parasites. Infections initiated i.v. with 106 PRBC (either phenotype) progressed at approximately the same rate and were uniformly fatal ( Fig. 1) . Treatment with cyclosporine (25 mg/kg) on days 5 and 6, when parasitemia levels averaged about 1%, did not affect the course of Cs' infections, whereas Css infections were reduced rapidly to undetectable levels (<0.01%). The latter recrudesced in all mice after 5 to 8 days and were progressive and lethal in most (data not shown). On the basis of these findings, sensitivity to cyclosporine was defined as a 100-fold or greater fall in the level of parasitemia within 48 h after administration of the first drug dose.
In an attempt to assess the stability of the Csr phenotype in the absence of cyclosporine, Csr parasites were subjected to 10 consecutive passages in mice (by blood inoculation) which were not treated with cyclosporine or to five mosquito-to-mouse transmission cycles. At every passage, when levels of parasitemia averaged about 5%, a tail blood sample was collected from each recipient mouse and inoculated into two or three normal indicator mice. Developing parasitemias of indicator mice were tested for cyclosporine sensitivity as defined above. In all instances, the Csr phenotype was retained.
Effect of cyclosporine on asexual erythrocytic-stage parasites. To determine the dynamics of cyclosporine-mediated parasite clearance, patently infected mice were given a single dose (25 mg/kg) of cyclosporine and observed for 24 h (Fig. 2) Table 1) .
The cyclosporine susceptibility of gametocytes was assessed at 9 days postinfection, when they could be easily enumerated in thin blood smears ( Fig. 3 and 4) through 48 h after the initiation of cyclosporine treatment. Infectivity for mosquitoes continued through 36 h.
Disassociation of cydosporine resistance and chloroquine resistance. Patent infections produced with either Cs' or Csr parasites were compared for their sensitivity to chloroquine. At a 30-mg/kg dose, parasites of both phenotypes showed equal susceptibility to chloroquine (data not shown).
Competence and competition of CsS and Csr parasites. During the course of our studies, Cs' parasites were more difficult to maintain by mosquito passage than those of the parental phenotype. To determine whether Csr parasites were less competent in the mosquito than Css parasites, separate groups of mice were infected with blood-stage parasites of each phenotype. Nine days later, half the animals in each group were given the first of two daily doses (25 mg/kg) of cyclosporine. Beginning at day 9 of infection and again after two consecutive 24-h periods, individual batches of 100 to 150 A. stephensi were fed on drug-treated and untreated mice from each group. Oocyst numbers were subsequently determined from dissections of mosquitoes. Despite similar levels of gametocytes in Cs'-and Csr_ parasite-infected untreated mice ( Fig. 3 and 4 stephensi. The 0-h point was immediately before the first cyclosporine injection and was day 9 after infection. This experiment used mice challenged with the same inoculum as that used for the experiment for which results are presented in Fig. 3 . Five mice were used per time point, and each mouse was separately exposed to between 100 and 150 female A. stephensi. Between days 9 and 11 after feeding, a minimum of 25 mosquitoes from each mouse feed were dissected to determine numbers of oocysts.
fewer oocysts were observed in mosquitoes fed on mice infected with Csr parasites. The results demonstrate that Csr parasites are less competent than Cs' parasites to develop in mosquitoes.
The comparative fitness of other developmental stages of the two parasite lines was tested. First, the relative capacity of asexual blood stages to grow in mice was investigated. Separate groups of mice were inoculated with 106 PRBC of the Css or Csr strain or with a mixture of 5 x 105 PRBC of each strain. The growth curves showed nearly identical rates of parasitemia for the three groups (Fig. 5) , indicating that when maintained separately, the two parasite lines are equally fit for development in mice.
For mice with mixed infections, further trials were conducted to determine whether Csr parasites constituted a large fraction of the parasitemia. It was reasoned that if a preponderance of CsS parasites was circulating in groups of such mice, cyclosporine injection would reduce parasitemia in proportion to the number of Css parasites. In two separate trials (the results for one are shown in Fig. 5 ), this approach demonstrated the persistence of large numbers of Csr parasites.
To determine whether prolongation of asexual-stage infection would result in the predominance of Cs' parasites, plasmodia were recovered from mice with patent mixed infections and subjected to four additional serial passages. Between 8 and 10 days after each passage, blood from three Although cyclosporine treatment of Cs' infection resulted in a significant decrease in circulating gametocytes, the rate of clearance was much slower for gametocytes than for asexual erythrocytic forms. The gametocytes which persisted remained infective to mosquitoes. The decrease in the level of gametocytemia may reflect the normal attrition of senescent forms and their lack of replacement because of interruption of the asexual cycle. The successful establishment of mosquito infection in the face of ongoing cyclosporine treatment demonstrates that the levels of cyclosporine imbibed with blood meals does not ablate syngamy or the progress of the initial stages of mosquito infection. Rather, the number of gametocytes ingested may have been markedly reduced.
Rosario et al. (7) have demonstrated that the acquisition of drug resistance by plasmodial parasites may be offset by alterations in the biological competence of parasite populations. For example, pyrimethamine resistance in P. chabaudi is associated with a biological debit: the drug-resistant parasites are less well fit to complete the life cycle than are wild-type parasites. On the other hand, chloroquine resistance (7) provides P. chabaudi with a distinct advantage under similar conditions, the acquisition of drug resistance being linked to an improved capacity to complete the life cycle. Our difficulty in passing Csr P. berghei through mosquitoes and the demonstration that mosquitoes fed Csr P. berghei developed fewer oocysts than those fed similar numbers of Css P. berghei suggest that the acquisition of the Csr trait is linked to changes which place resistant parasites at a biological disadvantage. When this proposition was tested by admixing Css and Csr parasite populations, the Csr trait was shown to reduce parasite competence. This was expressed as a lessened capacity of Csr parasites to complete the life cycle.
